Trial
NCT04004117
Effect of Sublingual Fentanyl on Breathlessness in COPD
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Collaborators
Canadian Institutes of Health Research (CIHR); Royal University Hospital, Saskatoon
Condition
Copd
Intervention
Fentanyl citrate solution sublingual
Why stopped
Clinical trial discontinued for reason pertaining to lack of efficacy.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-05